Semisynthetic hybrid biopolymers for non-pharmacological intervention of the microcirculation

Beatriz Y Salazar Vázquez, C. Makena Hightower, Ozlem Yalcin, Seetharama A. Acharya, Marcos Intaglietta

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The microcirculation presents functional organic structures in the range of 1-100 micrometers, commensurate with the upper end of nanotechnology constructs. When devices are designed and deployed to deliver treatment via the circulation they ultimately contend with the smallest dimensions of both healthy and impaired microvessels, particularly the capillary system whose ability to sustain the tissue is assessed by measuring "functional capillary density" (FCD). FCD is directly determined by hydrostatic and osmotic pressures and indirectly by the effect of cardiovascular regulators, particularly the bioavailability of nitric oxide (NO) resulting from fluid mechanical effects and transport in the submicroscopic cell free plasma layer (CFL) located between blood and microvascular wall. Mac-romolecules using colloids as templates that are surface decorated with polyethylene glycol (PEG) become immuno-invisible and can be introduced into the circulation to manipulate the NO environment in blood and the endothelium. PEG-albumin is a class of molecules with novel plasma expansion properties that directly interacts with the microcirculation via CFL related effects. The principal application of this technology is in transfusion medicine and the plasma expanders used to treat blood losses and concomitant effects on microvascu-lar function due to related acute inflammatory conditions and ischemia.

Original languageEnglish (US)
Pages (from-to)540-546
Number of pages7
JournalCurrent Drug Metabolism
Volume14
Issue number5
DOIs
StatePublished - Jun 2013

Fingerprint

Microcirculation
Biopolymers
Plasma Cells
Plasmas
Blood
Nitric Oxide
Transfusion Medicine
Nanotechnology
Hydrostatic Pressure
Osmotic Pressure
Colloids
Microvessels
Biological Availability
Endothelium
Albumins
Ischemia
Medicine
Technology
Equipment and Supplies
Tissue

Keywords

  • Cell free layer
  • Functional capillary density
  • Microcirculation
  • PEG-albumin
  • Plasma expanders

ASJC Scopus subject areas

  • Pharmacology
  • Clinical Biochemistry

Cite this

Vázquez, B. Y. S., Hightower, C. M., Yalcin, O., Acharya, S. A., & Intaglietta, M. (2013). Semisynthetic hybrid biopolymers for non-pharmacological intervention of the microcirculation. Current Drug Metabolism, 14(5), 540-546. https://doi.org/10.2174/13892002113149990011

Semisynthetic hybrid biopolymers for non-pharmacological intervention of the microcirculation. / Vázquez, Beatriz Y Salazar; Hightower, C. Makena; Yalcin, Ozlem; Acharya, Seetharama A.; Intaglietta, Marcos.

In: Current Drug Metabolism, Vol. 14, No. 5, 06.2013, p. 540-546.

Research output: Contribution to journalArticle

Vázquez, BYS, Hightower, CM, Yalcin, O, Acharya, SA & Intaglietta, M 2013, 'Semisynthetic hybrid biopolymers for non-pharmacological intervention of the microcirculation', Current Drug Metabolism, vol. 14, no. 5, pp. 540-546. https://doi.org/10.2174/13892002113149990011
Vázquez, Beatriz Y Salazar ; Hightower, C. Makena ; Yalcin, Ozlem ; Acharya, Seetharama A. ; Intaglietta, Marcos. / Semisynthetic hybrid biopolymers for non-pharmacological intervention of the microcirculation. In: Current Drug Metabolism. 2013 ; Vol. 14, No. 5. pp. 540-546.
@article{60e179c6963a46dc8ad2af4470f41558,
title = "Semisynthetic hybrid biopolymers for non-pharmacological intervention of the microcirculation",
abstract = "The microcirculation presents functional organic structures in the range of 1-100 micrometers, commensurate with the upper end of nanotechnology constructs. When devices are designed and deployed to deliver treatment via the circulation they ultimately contend with the smallest dimensions of both healthy and impaired microvessels, particularly the capillary system whose ability to sustain the tissue is assessed by measuring {"}functional capillary density{"} (FCD). FCD is directly determined by hydrostatic and osmotic pressures and indirectly by the effect of cardiovascular regulators, particularly the bioavailability of nitric oxide (NO) resulting from fluid mechanical effects and transport in the submicroscopic cell free plasma layer (CFL) located between blood and microvascular wall. Mac-romolecules using colloids as templates that are surface decorated with polyethylene glycol (PEG) become immuno-invisible and can be introduced into the circulation to manipulate the NO environment in blood and the endothelium. PEG-albumin is a class of molecules with novel plasma expansion properties that directly interacts with the microcirculation via CFL related effects. The principal application of this technology is in transfusion medicine and the plasma expanders used to treat blood losses and concomitant effects on microvascu-lar function due to related acute inflammatory conditions and ischemia.",
keywords = "Cell free layer, Functional capillary density, Microcirculation, PEG-albumin, Plasma expanders",
author = "V{\'a}zquez, {Beatriz Y Salazar} and Hightower, {C. Makena} and Ozlem Yalcin and Acharya, {Seetharama A.} and Marcos Intaglietta",
year = "2013",
month = "6",
doi = "10.2174/13892002113149990011",
language = "English (US)",
volume = "14",
pages = "540--546",
journal = "Current Drug Metabolism",
issn = "1389-2002",
publisher = "Bentham Science Publishers B.V.",
number = "5",

}

TY - JOUR

T1 - Semisynthetic hybrid biopolymers for non-pharmacological intervention of the microcirculation

AU - Vázquez, Beatriz Y Salazar

AU - Hightower, C. Makena

AU - Yalcin, Ozlem

AU - Acharya, Seetharama A.

AU - Intaglietta, Marcos

PY - 2013/6

Y1 - 2013/6

N2 - The microcirculation presents functional organic structures in the range of 1-100 micrometers, commensurate with the upper end of nanotechnology constructs. When devices are designed and deployed to deliver treatment via the circulation they ultimately contend with the smallest dimensions of both healthy and impaired microvessels, particularly the capillary system whose ability to sustain the tissue is assessed by measuring "functional capillary density" (FCD). FCD is directly determined by hydrostatic and osmotic pressures and indirectly by the effect of cardiovascular regulators, particularly the bioavailability of nitric oxide (NO) resulting from fluid mechanical effects and transport in the submicroscopic cell free plasma layer (CFL) located between blood and microvascular wall. Mac-romolecules using colloids as templates that are surface decorated with polyethylene glycol (PEG) become immuno-invisible and can be introduced into the circulation to manipulate the NO environment in blood and the endothelium. PEG-albumin is a class of molecules with novel plasma expansion properties that directly interacts with the microcirculation via CFL related effects. The principal application of this technology is in transfusion medicine and the plasma expanders used to treat blood losses and concomitant effects on microvascu-lar function due to related acute inflammatory conditions and ischemia.

AB - The microcirculation presents functional organic structures in the range of 1-100 micrometers, commensurate with the upper end of nanotechnology constructs. When devices are designed and deployed to deliver treatment via the circulation they ultimately contend with the smallest dimensions of both healthy and impaired microvessels, particularly the capillary system whose ability to sustain the tissue is assessed by measuring "functional capillary density" (FCD). FCD is directly determined by hydrostatic and osmotic pressures and indirectly by the effect of cardiovascular regulators, particularly the bioavailability of nitric oxide (NO) resulting from fluid mechanical effects and transport in the submicroscopic cell free plasma layer (CFL) located between blood and microvascular wall. Mac-romolecules using colloids as templates that are surface decorated with polyethylene glycol (PEG) become immuno-invisible and can be introduced into the circulation to manipulate the NO environment in blood and the endothelium. PEG-albumin is a class of molecules with novel plasma expansion properties that directly interacts with the microcirculation via CFL related effects. The principal application of this technology is in transfusion medicine and the plasma expanders used to treat blood losses and concomitant effects on microvascu-lar function due to related acute inflammatory conditions and ischemia.

KW - Cell free layer

KW - Functional capillary density

KW - Microcirculation

KW - PEG-albumin

KW - Plasma expanders

UR - http://www.scopus.com/inward/record.url?scp=84881625820&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881625820&partnerID=8YFLogxK

U2 - 10.2174/13892002113149990011

DO - 10.2174/13892002113149990011

M3 - Article

C2 - 23687928

AN - SCOPUS:84881625820

VL - 14

SP - 540

EP - 546

JO - Current Drug Metabolism

JF - Current Drug Metabolism

SN - 1389-2002

IS - 5

ER -